NASDAQ:VKTX

Viking Therapeutics Stock Predictions

etoro logo Buy VKTX
*Your capital is at risk
$29.33
+0.0400 (+0.137%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

VKTX Prediction Chart

VKTX Predictions History

Latest community submissions for VKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
May 29, 2026 $31.77 -1.30% $32.74 X 97.04% 0
May 29, 2026 $31.63 -1.74% $32.74 X 96.61% 0
May 29, 2026 $31.84 -1.09% $32.74 X 97.25% 0
JS JS Pro
May 29, 2026 $32.55 +1.12% $32.74 V 99.42% 4
May 29, 2026 Bullish $32.74 V 1
Feb 12, 2026 $27.80 -2.62% $30.49 X 91.19% 0
Feb 12, 2026 $29.02 +1.64% $30.49 V 95.17% 1
Feb 12, 2026 Bullish $30.49 V 1
Feb 10, 2026 $28.52 -2.65% $28.75 V 99.21% 3
Feb 10, 2026 $28.81 -1.66% $28.75 V 99.77% 6
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIKING THERAPEUTICS
Viking Therapeutics
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE